Follow
loqmane seridi
loqmane seridi
Scientist, Johnson & Johnson Pharmaceutical Research and Development
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Specificity and transcriptional activity of microbiota associated with low and high microbial abundance sponges from the Red Sea
L Moitinho‐Silva, K Bayer, CV Cannistraci, EC Giles, T Ryu, L Seridi, ...
Molecular ecology 23 (6), 1348-1363, 2014
1462014
Molecular processes of transgenerational acclimation to a warming ocean
HD Veilleux, T Ryu, JM Donelson, L Van Herwerden, L Seridi, Y Ghosheh, ...
Nature Climate Change 5 (12), 1074-1078, 2015
1382015
Hologenome analysis of two marine sponges with different microbiomes
T Ryu, L Seridi, L Moitinho-Silva, M Oates, YJ Liew, C Mavromatis, ...
BMC genomics 17, 1-11, 2016
752016
Revealing microbial functional activities in the Red Sea sponge Stylissa carteri by metatranscriptomics
L Moitinho‐Silva, L Seridi, T Ryu, CR Voolstra, T Ravasi, U Hentschel
Environmental Microbiology 16 (12), 3683-3698, 2014
752014
Characterization of piRNAs across postnatal development in mouse brain
Y Ghosheh, L Seridi, T Ryu, H Takahashi, V Orlando, P Carninci, T Ravasi
Scientific reports 6 (1), 25039, 2016
382016
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus
RF van Vollenhoven, KC Kalunian, T Dörner, BH Hahn, Y Tanaka, ...
Annals of the rheumatic diseases 81 (11), 1556-1563, 2022
352022
The evolution of ultraconserved elements with different phylogenetic origins
T Ryu, L Seridi, T Ravasi
BMC evolutionary biology 12, 1-11, 2012
342012
Nuclear AGO1 regulates gene expression by affecting chromatin architecture in human cells
M Shuaib, KM Parsi, M Thimma, SA Adroub, H Kawaji, L Seridi, ...
Cell systems 9 (5), 446-458. e6, 2019
292019
Transcriptome analysis elucidates key developmental components of bryozoan lophophore development
YH Wong, T Ryu, L Seridi, Y Ghosheh, S Bougouffa, PY Qian, T Ravasi
Scientific reports 4 (1), 6534, 2014
242014
Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome
L Seridi, GC Leo, GL Dohm, WJ Pories, J Lenhard
PLoS One 13 (5), e0198156, 2018
212018
Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus
M Cesaroni, L Seridi, MJ Loza, J Schreiter, K Sweet, C Franks, K Ma, ...
Arthritis & Rheumatology 73 (3), 472-477, 2021
182021
Transcriptome and proteome dynamics in larvae of the barnacle Balanus Amphitrite from the Red Sea
KH Chandramouli, S Al-Aqeel, T Ryu, H Zhang, L Seridi, Y Ghosheh, ...
BMC genomics 16, 1-17, 2015
162015
Dynamic epigenetic control of highly conserved noncoding elements
L Seridi, T Ryu, T Ravasi
PLoS One 9 (10), e109326, 2014
102014
First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial
J Jordan, J Benson, WW Chatham, RA Furie, W Stohl, JCC Wei, ...
The Lancet Rheumatology 2 (10), e613-e622, 2020
52020
Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition
L Seridi, M Cesaroni, A Orillion, J Schreiter, M Chevrier, S Marciniak, ...
Lupus 30 (5), 795-806, 2021
42021
Response to ustekinumab treatment in patients with systemic lupus erythematosus is linked to suppression of serum interferon gamma levels
M Cesaroni, L Seridi, MJ Loza, J Schreiter, K Sweet, C Franks
Arthritis Rheumatol 73 (3), 10.1002, 2020
32020
OP0278 biomarker profiling reveals novel mechanistic insights into ustekinumab therapeutic responses in systemic lupus erythematosus
M Cesaroni, L Seridi, J Jordan, K Sweet, MA Keying, C Franks, J Schreiter, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 220-221, 2019
32019
AGO1 in association with NEAT1 lncRNA contributes to nuclear and 3D chromatin architecture in human cells
M Shuaib, KM Parsi, H Kawaji, M Thimma, SA Adroub, A Fort, Y Ghosheh, ...
bioRxiv, 525527, 2019
32019
OP0161 association of baseline cytotoxic gene expression with ustekinumab response in systemic lupus erythematosus
L Seridi, M Cesaroni, MJ Loza, J Schreiter, K Sweet, Y Orlovsky, ...
Annals of the Rheumatic Diseases 79 (Suppl 1), 101-102, 2020
22020
251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus
J Jordan, K Sweet, M Cesaroni, K Ma, C Franks, L Seridi, J Schreiter, ...
Lupus Science & Medicine 6 (Suppl 1), 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–20